drugset / Trial / NCT03391193
Immunogenicity and Safety of a Multi-Dose Quadrivalent Influenza Vaccine
RandomizedParallel-groupOpen-labelPrevention
Summary
The aim of the study is to to assess the immunogenicity and safety of a quadrivalent influenza vaccine in a multi-dose presentation compared to a quadrivalent influenza vaccine in single-dose presentation, in children aged 6 months to 17 years.
Timeline
- Start
- 2017-12-19
- Primary completion
- 2018-03-28
- Completion
- 2018-08-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Multi-dose Quadrivalent Influenza Vaccine | Vaccine | 0.5 ml | Intramuscular |
| Comparator | NITRAMINE | Vaccine | 0.5 ml | Intramuscular |